Publications by authors named "Per Rathenborg"

Claim this Profile
P
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer.
James L Gulley, Michael Borre, Nicholas J Vogelzang, Siobhan Ng, Neeraj Agarwal, Per Rathenborg

J Clin Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal Shore

N Engl J Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results.
Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel

J Urol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results.
Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel

Eur Urol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metastatic adenocarcinoma in preputium of a patient with oesophageal cancer].
Christina Lindkvist Pedersen, Per Zier Rathenborg

Ugeskr Laeger· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate.
Frederik Birkebaek Thomsen, Martin Andreas Røder, Per Rathenborg, Klaus Brasso, Michael Borre

Scand J Urol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study.
Bertrand Tombal, Michael Borre, Per Rathenborg, Patrick Werbrouck, Hendrik Van Poppel

Lancet Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ease of removal of thermo-expandable prostate stents.
Neil J Barber, Alison J Roodhouse, Per Rathenborg, Jørgen Nordling, Brian W Ellis

BJU Int· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis